Intraperitoneal port placement at the time of primary cytoreduction with rectosigmoid resection for advanced ovarian cancer

被引：0
|
作者：
Kehoe, S. M. [1 ]
Zivanovic, O. [1 ]
Dottino, J. [1 ]
Sonoda, Y. [1 ]
Levine, D. A. [1 ]
Abu-Rustum, N. R. [1 ]
Barakat, R. R. [1 ]
Chi, D. S. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Gynecol Oncol Surg, New York, NY 10021 USA
来源：
GYNECOLOGIC ONCOLOGY | 2009年 / 112卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
273
引用
收藏
页码：S139 / S139
页数：1
相关论文
共 50 条
  • [41] A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer
    Suidan, Rudy S.
    Clair, Caryn M. St.
    Lee, Stephen J.
    Barlin, Joyce N.
    Roche, Kara C. Long
    Tanner, Edward J.
    Sonoda, Yukio
    Barakat, Richard R.
    Zivanovic, Oliver
    Chi, Dennis S.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (03) : 468 - 472
  • [42] Does operative start time impact the frequency of complete gross resection in patients undergoing primary cytoreduction for advanced serous ovarian carcinoma?
    Tanner, E.
    Long, K.
    Zhou, Q.
    Brightwell, R.
    Gardner, G.
    Abu-Rustum, N.
    Leitao, M.
    Sonoda, Y.
    Barakat, R.
    Iasonos, A.
    Chi, D.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (02) : S2 - S2
  • [43] Unanticipated 30-day readmission following rectosigmoid resection at the time of cytoreductive surgery in patients with advanced stage ovarian cancer
    Sanders, Brooke E.
    Saharti, Samah
    Laus, Katharina
    Bristow, Robert E.
    Eskander, Ramez N.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 41 (06) : 956 - 961
  • [44] Comparison of Primary Intraperitoneal Chemotherapy to Consolidation Intraperitoneal Chemotherapy in Optimally Resected Advanced Ovarian Cancer
    Suidan, Rudy S.
    St Clair, Caryn M.
    Lee, Stephen J.
    Barlin, Joyce N.
    Roche, Kara C. Long
    Tanner, Edward J.
    Sonoda, Yukio
    Barakat, Richard R.
    Zivanovic, Oliver
    Chi, Dennis S.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2014, 69 (12) : 741 - 742
  • [45] PLANNING OF CYTOREDUCTION SURGERY (PRIMARY OR INTERVAL) IN ADVANCED OVARIAN CANCER AND RESULTANT OUTCOME OF PATIENTS
    Vermeulen, C. K. M.
    Tadesse, W.
    Walsh, T.
    Kruitwagen, R. F. P. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 854 - 854
  • [46] Laparoscopic-assisted cytoreduction for primary advanced ovarian cancer: Success, morbidity and survival
    Fanning, James
    Yacoub, Emmanuel
    Hojat, Rod
    GYNECOLOGIC ONCOLOGY, 2011, 123 (01) : 47 - 49
  • [47] Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: The evolution of a "pelvic" surgeon
    Fotopoulou, Christina
    GYNECOLOGIC ONCOLOGY, 2023, 170 : A1 - A3
  • [48] LAPAROSCOPIC SECONDARY CYTOREDUCTION AND HYPERTHERMIA INTRAPERITONEAL CHEMOTHERAPY FOR RECURRENT OVARIAN CANCER
    Naki, M. M.
    Karabuk, E.
    Alkhan, F.
    Gungor, M.
    Kose, M. K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1402 - 1402
  • [49] What Should We Expect After a Complete Cytoreduction at the Time of Interval or Primary Debulking Surgery in Advanced Ovarian Cancer?
    Luis Chiva
    Fernando Lapuente
    Teresa Castellanos
    Sonsoles Alonso
    Antonio Gonzalez-Martin
    Annals of Surgical Oncology, 2016, 23 : 1666 - 1673
  • [50] WHAT SHOULD WE EXPECT AFTER A COMPLETE CYTOREDUCTION AT THE TIME OF PRIMARY OR INTERVAL DEBULKING SURGERY IN ADVANCED OVARIAN CANCER?
    Chiva, L.
    Alonso, S.
    Castellanos, T.
    Lapuente, F.
    Bratos, R.
    Marquez, R.
    Gonzalez-Martin, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 402 - 403
12345